Biomark Scientific is a microfluidics technology tools provider specializing in high-throughput genomics systems. Its flagship Biomark™ platform delivers scalable, automated genomic profiling for research institutions, public health laboratories, and biobanks. The Biomark X9 is the only system on the market that automates genetic amplification and sequencing preparation, using patented integrated fluidic circuits to profile multiple assay types in a single run. Biomark Scientific became a standalone business in 2026 as part of ARCHIMED.